These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29562506)

  • 1. Multi-Faceted Role of Melatonin in Neuroprotection and Amelioration of Tau Aggregates in Alzheimer's Disease.
    Balmik AA; Chinnathambi S
    J Alzheimers Dis; 2018; 62(4):1481-1493. PubMed ID: 29562506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of melatonin in Alzheimer-like neurodegeneration.
    Wang JZ; Wang ZF
    Acta Pharmacol Sin; 2006 Jan; 27(1):41-9. PubMed ID: 16364209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin interacts with repeat domain of Tau to mediate disaggregation of paired helical filaments.
    Balmik AA; Das R; Dangi A; Gorantla NV; Marelli UK; Chinnathambi S
    Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129467. PubMed ID: 31715192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin in Alzheimer's disease.
    Lin L; Huang QX; Yang SS; Chu J; Wang JZ; Tian Q
    Int J Mol Sci; 2013 Jul; 14(7):14575-93. PubMed ID: 23857055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin Reduces GSK3β-Mediated Tau Phosphorylation, Enhances Nrf2 Nuclear Translocation and Anti-Inflammation.
    Das R; Balmik AA; Chinnathambi S
    ASN Neuro; 2020; 12():1759091420981204. PubMed ID: 33342257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.
    Hossain MF; Uddin MS; Uddin GMS; Sumsuzzman DM; Islam MS; Barreto GE; Mathew B; Ashraf GM
    Mol Neurobiol; 2019 Dec; 56(12):8255-8276. PubMed ID: 31209782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The melatonin-N,N-dibenzyl(N-methyl)amine hybrid ITH91/IQM157 affords neuroprotection in an in vitro Alzheimer's model via hemo-oxygenase-1 induction.
    Buendia I; Egea J; Parada E; Navarro E; León R; Rodríguez-Franco MI; López MG
    ACS Chem Neurosci; 2015 Feb; 6(2):288-96. PubMed ID: 25393881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTor mediates tau localization and secretion: Implication for Alzheimer's disease.
    Tang Z; Ioja E; Bereczki E; Hultenby K; Li C; Guan Z; Winblad B; Pei JJ
    Biochim Biophys Acta; 2015 Jul; 1853(7):1646-57. PubMed ID: 25791428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.
    Jouanne M; Rault S; Voisin-Chiret AS
    Eur J Med Chem; 2017 Oct; 139():153-167. PubMed ID: 28800454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer's disease.
    Balmik AA; Chinnathambi S
    Cell Commun Signal; 2021 May; 19(1):51. PubMed ID: 33962636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zn
    Li X; Du X; Ni J
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
    Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
    Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
    Ali T; Kim MO
    J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of melatonin in experimental models of Alzheimer disease.
    Cheng Y; Feng Z; Zhang QZ; Zhang JT
    Acta Pharmacol Sin; 2006 Feb; 27(2):129-39. PubMed ID: 16412260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Melatonin on Tau aggregation and Tau-mediated cell surface morphology.
    Das R; Balmik AA; Chinnathambi S
    Int J Biol Macromol; 2020 Jun; 152():30-39. PubMed ID: 32044365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagic Pathways to Clear the Tau Aggregates in Alzheimer's Disease.
    Gorantla NV; Chinnathambi S
    Cell Mol Neurobiol; 2021 Aug; 41(6):1175-1181. PubMed ID: 32529542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.